Progesterone for the prevention of preterm birth - A systematic review

被引:99
作者
Dodd, Jodie M.
Flenady, Vicki J.
Cincotta, Robert
Crowther, Caroline A.
机构
[1] Univ Adelaide, Discipline Obstet & Gynaecol, Adelaide, SA, Australia
[2] Mater Mothers Hosp, Clin Res Ctr, Brisbane, Qld, Australia
关键词
D O I
10.1097/AOG.0b013e31817d0262
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: We performed a systematic review to assess the benefits and harms of progesterone administration for the prevention of preterm birth in women and their infants. DATA SOURCES: The Cochrane Controlled Trials Register was searched, and reference lists of retrieved studies were searched by hand. No date or language restrictions were placed. METHODS OF STUDY SELECTION: Randomized trials comparing antenatal progesterone for women at risk of preterm birth were considered. Studies were evaluated for inclusion and methodological quality. Primary outcomes were perinatal death, preterm birth before 34 weeks, and neurodevelopmental handicap. TABULATION, INTEGRATION AND RESULTS: Eleven randomized controlled trials (2,425 women and 3,187 infants) were included. For women with a history of spontaneous preterm birth, progesterone was associated with a significant reduction in preterm birth before 34 weeks (one study, 142 women, RR 0.15, 95% Cl 0.04-0.64, number needed to treat 7, 95% CI 4-17), but no statistically significant differences were identified for the outcome of perinatal death. For women with a short cervix identified on ultrasound, progesterone was not associated with a significant difference in perinatal death (one study, 274 participants, RR 0.38, 95% CI 0.10-1.40), but there was a significant reduction in preterm birth before 34 weeks (one study, 250 women, RR 0.58, 95% CI 0.38-0.87, number needed to treat 7, 95% CI 4-25). For women with a multiple pregnancy, progesterone was associated with no significant difference in perinatal death (one, study, 154 participants, RR 1.95, 95% CI 0.37-10.33). For women presenting after threatened preterm labor, no primary outcomes were reported. For women with "other" risk factors for preterm birth, progesterone was not associated with a significant difference in perinatal death (two studies, 264 participants, RR 1.10, 95% Cl 0.23-5.29). CONCLUSION: Progesterone is associated with some beneficial effects in pregnancy outcome for some women at increased risk of preterm birth.
引用
收藏
页码:127 / 134
页数:8
相关论文
共 54 条
[1]   Rates of and factors associated with recurrence of preterm delivery [J].
Adams, MM ;
Elam-Evans, LD ;
Wilson, HG ;
Gilbertz, DA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (12) :1591-1596
[2]  
American College of Obstetricians and Gynecologists, 2003, OBSTET GYNECOL, V102, P1115
[3]  
[Anonymous], DOUBLE BLIND RANDOMI
[4]  
Astle S, 2003, EUR J OBSTET GYN R B, V108, P177
[5]   TENDENCY TO REPEAT GESTATIONAL-AGE AND BIRTH-WEIGHT IN SUCCESSIVE BIRTHS [J].
BAKKETEIG, LS ;
HOFFMAN, HJ ;
HARLEY, EE .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1979, 135 (08) :1086-1103
[6]   EPIDEMIOLOGY OF PRETERM BIRTH [J].
BERKOWITZ, GS ;
PAPIERNIK, E .
EPIDEMIOLOGIC REVIEWS, 1993, 15 (02) :414-443
[7]   Preterm birth and multiple pregnancy in European countries participating in the PERISTAT project [J].
Blondel, B ;
Macfarlane, A ;
Gissler, M ;
Breart, G ;
Zeitlin, J .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 113 (05) :528-535
[8]   Recurrence of preterm birth in singleton and twin pregnancies [J].
Bloom, SL ;
Yost, NP ;
McIntire, DD ;
Leveno, KJ .
OBSTETRICS AND GYNECOLOGY, 2001, 98 (03) :379-385
[9]   Progesterone for maintenance tocolytic therapy after threatened preterm labour: A randomised controlled trial [J].
Borna, Sedigheh ;
Sahabi, Noshin .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2008, 48 (01) :58-63
[10]  
Breart G, 1979, Int J Gynaecol Obstet, V16, P381